Masashi Kanai

Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer

Junzo Hamanishi, Masaki Mandai, Takafumi Ikeda et al. · Journal of Clinical Oncology · 2015 · 1.2K citations

Medicine, Oncology, Pharmacology +17

A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer

Masashi Kanai, Kenichi Yoshimura, Masanori Asada et al. · Cancer Chemotherapy and Pharmacology · 2010 · 398 citations · Full text

Medicine, Oncology, Pharmacology +10

STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells

Naoki Kanda, Hiroshi Seno, Yoshitaka Konda et al. · Oncogene · 2004 · 306 citations · Full text

Medicine, Molecular Biology, Oncology +13

Drastic Down-regulation of Kruppel-Like Factor 4 Expression Is Critical in Human Gastric Cancer Development and Progression

Daoyan Wei, Weida Gong, Masashi Kanai et al. · Cancer Research · 2005 · 295 citations

Medicine, Molecular Biology, Oncology +17

Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers

Masashi Kanai, Atsushi Imaizumi, Yoshihiko Otsuka et al. · Cancer Chemotherapy and Pharmacology · 2011 · 253 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17